CLIMACTERIC SYNDROME TREATMENT METHOD
FIELD: gynecology. ^ SUBSTANCE: synthoxic program activity adaptation factor (SPAAF) is derived from following equation: SPAAF = (Cst%+Aat-III%+Agoap%+ Cts%)/(Cad%+Ca2mg%+Cmda%+Cth%), where Cst signifies blood concentration of serotonin, Aat-III antithrombin III activity, Agoap general oxidation act...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; rus |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DARMOGRAJ V.N KHADARTSEV A.A MOROZOVA V.I MOROZOV V.N KARASEVA JU.V |
| description | FIELD: gynecology. ^ SUBSTANCE: synthoxic program activity adaptation factor (SPAAF) is derived from following equation: SPAAF = (Cst%+Aat-III%+Agoap%+ Cts%)/(Cad%+Ca2mg%+Cmda%+Cth%), where Cst signifies blood concentration of serotonin, Aat-III antithrombin III activity, Agoap general oxidation activity of plasma, Cts T-suppressor concentration, Cad blood concentration of adrenaline, Ca2mga2-macroglobulin concentration, Cmd malonic dialdehyde concentration, and Cth T-helper concentration. Above concentrations and activity are expressed in % based on reference values found in sound males and females 45 to 55 years of age. When SPAAF equals 0.7, pyroxane in dose 0.015 g twice a day over a 7 days period and 0.005-0.01% phytoecdisterone in 40% alcohol in dose 30 drops thrice a day before meal over 2 weeks period are simultaneously administered. When SPAAF equals 0.5, the same treatment is prescribed but pyroxane is administered for 2 weeks and on the 15th day after the last administration the course is repeated. ^ EFFECT: stabilized arterial pressure, normalized metabolism, and improved cerebral blood circulation. ^ 2 ex |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2258505C1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2258505C1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2258505C13</originalsourceid><addsrcrecordid>eNrjZFB19vH0dXQOcQ3ydFYIjvRzCfL3dVUICXJ1DPF19QtR8HUN8fB34WFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8UGhRkamFqYGps6GxkQoAQB0yCM4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CLIMACTERIC SYNDROME TREATMENT METHOD</title><source>esp@cenet</source><creator>DARMOGRAJ V.N ; KHADARTSEV A.A ; MOROZOVA V.I ; MOROZOV V.N ; KARASEVA JU.V</creator><creatorcontrib>DARMOGRAJ V.N ; KHADARTSEV A.A ; MOROZOVA V.I ; MOROZOV V.N ; KARASEVA JU.V</creatorcontrib><description>FIELD: gynecology. ^ SUBSTANCE: synthoxic program activity adaptation factor (SPAAF) is derived from following equation: SPAAF = (Cst%+Aat-III%+Agoap%+ Cts%)/(Cad%+Ca2mg%+Cmda%+Cth%), where Cst signifies blood concentration of serotonin, Aat-III antithrombin III activity, Agoap general oxidation activity of plasma, Cts T-suppressor concentration, Cad blood concentration of adrenaline, Ca2mga2-macroglobulin concentration, Cmd malonic dialdehyde concentration, and Cth T-helper concentration. Above concentrations and activity are expressed in % based on reference values found in sound males and females 45 to 55 years of age. When SPAAF equals 0.7, pyroxane in dose 0.015 g twice a day over a 7 days period and 0.005-0.01% phytoecdisterone in 40% alcohol in dose 30 drops thrice a day before meal over 2 weeks period are simultaneously administered. When SPAAF equals 0.5, the same treatment is prescribed but pyroxane is administered for 2 weeks and on the 15th day after the last administration the course is repeated. ^ EFFECT: stabilized arterial pressure, normalized metabolism, and improved cerebral blood circulation. ^ 2 ex</description><edition>7</edition><language>eng ; rus</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050820&DB=EPODOC&CC=RU&NR=2258505C1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050820&DB=EPODOC&CC=RU&NR=2258505C1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DARMOGRAJ V.N</creatorcontrib><creatorcontrib>KHADARTSEV A.A</creatorcontrib><creatorcontrib>MOROZOVA V.I</creatorcontrib><creatorcontrib>MOROZOV V.N</creatorcontrib><creatorcontrib>KARASEVA JU.V</creatorcontrib><title>CLIMACTERIC SYNDROME TREATMENT METHOD</title><description>FIELD: gynecology. ^ SUBSTANCE: synthoxic program activity adaptation factor (SPAAF) is derived from following equation: SPAAF = (Cst%+Aat-III%+Agoap%+ Cts%)/(Cad%+Ca2mg%+Cmda%+Cth%), where Cst signifies blood concentration of serotonin, Aat-III antithrombin III activity, Agoap general oxidation activity of plasma, Cts T-suppressor concentration, Cad blood concentration of adrenaline, Ca2mga2-macroglobulin concentration, Cmd malonic dialdehyde concentration, and Cth T-helper concentration. Above concentrations and activity are expressed in % based on reference values found in sound males and females 45 to 55 years of age. When SPAAF equals 0.7, pyroxane in dose 0.015 g twice a day over a 7 days period and 0.005-0.01% phytoecdisterone in 40% alcohol in dose 30 drops thrice a day before meal over 2 weeks period are simultaneously administered. When SPAAF equals 0.5, the same treatment is prescribed but pyroxane is administered for 2 weeks and on the 15th day after the last administration the course is repeated. ^ EFFECT: stabilized arterial pressure, normalized metabolism, and improved cerebral blood circulation. ^ 2 ex</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFB19vH0dXQOcQ3ydFYIjvRzCfL3dVUICXJ1DPF19QtR8HUN8fB34WFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8UGhRkamFqYGps6GxkQoAQB0yCM4</recordid><startdate>20050820</startdate><enddate>20050820</enddate><creator>DARMOGRAJ V.N</creator><creator>KHADARTSEV A.A</creator><creator>MOROZOVA V.I</creator><creator>MOROZOV V.N</creator><creator>KARASEVA JU.V</creator><scope>EVB</scope></search><sort><creationdate>20050820</creationdate><title>CLIMACTERIC SYNDROME TREATMENT METHOD</title><author>DARMOGRAJ V.N ; KHADARTSEV A.A ; MOROZOVA V.I ; MOROZOV V.N ; KARASEVA JU.V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2258505C13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2005</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DARMOGRAJ V.N</creatorcontrib><creatorcontrib>KHADARTSEV A.A</creatorcontrib><creatorcontrib>MOROZOVA V.I</creatorcontrib><creatorcontrib>MOROZOV V.N</creatorcontrib><creatorcontrib>KARASEVA JU.V</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DARMOGRAJ V.N</au><au>KHADARTSEV A.A</au><au>MOROZOVA V.I</au><au>MOROZOV V.N</au><au>KARASEVA JU.V</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CLIMACTERIC SYNDROME TREATMENT METHOD</title><date>2005-08-20</date><risdate>2005</risdate><abstract>FIELD: gynecology. ^ SUBSTANCE: synthoxic program activity adaptation factor (SPAAF) is derived from following equation: SPAAF = (Cst%+Aat-III%+Agoap%+ Cts%)/(Cad%+Ca2mg%+Cmda%+Cth%), where Cst signifies blood concentration of serotonin, Aat-III antithrombin III activity, Agoap general oxidation activity of plasma, Cts T-suppressor concentration, Cad blood concentration of adrenaline, Ca2mga2-macroglobulin concentration, Cmd malonic dialdehyde concentration, and Cth T-helper concentration. Above concentrations and activity are expressed in % based on reference values found in sound males and females 45 to 55 years of age. When SPAAF equals 0.7, pyroxane in dose 0.015 g twice a day over a 7 days period and 0.005-0.01% phytoecdisterone in 40% alcohol in dose 30 drops thrice a day before meal over 2 weeks period are simultaneously administered. When SPAAF equals 0.5, the same treatment is prescribed but pyroxane is administered for 2 weeks and on the 15th day after the last administration the course is repeated. ^ EFFECT: stabilized arterial pressure, normalized metabolism, and improved cerebral blood circulation. ^ 2 ex</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; rus |
| recordid | cdi_epo_espacenet_RU2258505C1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | CLIMACTERIC SYNDROME TREATMENT METHOD |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T11%3A41%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DARMOGRAJ%20V.N&rft.date=2005-08-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2258505C1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |